Michelson Prize and Grants in Reproductive Biology

Source: Wikipedia, the free encyclopedia.

The Michelson Prize and Grants in Reproductive Biology Program is a $75 million (USD) initiative to create a safe and effective, single-dose, nonsurgical sterilant for male and female cats and dogs.[1] It includes a $25 million (USD) prize for the first entity to develop a product that meets a series of criteria, which include: a single-dose, permanent, nonsurgical sterilant; safe and effective in male and female cats and dogs, ablates sex steroids and/or their effects, suitable for administration in a field setting, viable pathway to regulatory approval, and reasonable manufacturing process and cost.[2] The program has also committed up to $50 million (USD) in grant funding for promising research in pursuit of a sterilant that meets these criteria. To date, $19 million has been awarded to 41 research projects worldwide, including a 2023 study on durable anti-Mullerian hormone treatments for female cats.[3][4]

The prize was established in October 2008 by the Found Animals Foundation, a

orthopedic surgeon, inventor and entrepreneur, the Michelson Prize and Grants Program seeks to make sterilization for cats and dogs globally accessible and affordable worldwide through a high-volume, low-profit model.[5][6]

See also

References

  1. ^ Peters, Sharon L. (2008-10-15). "Inventor Michelson offers $75M for a way to sterilize pets". Usatoday.Com. Retrieved 2012-10-31.
  2. ^ Conlon, Thomas (September 3, 2018). "The Michelson Prize & Grants: past, present, future". youtube.com/watch?v=4bagH2Eas50. Retrieved January 5, 2019.
  3. .
  4. ^ Vaughan, Don (2022-08-30). "Giving It Their Best Shot". Today's Veterinary Business. Retrieved 2024-04-12.
  5. ^ "Scientific research increasingly fueled by prize money". Retrieved 2018-02-16.
  6. ^ Whelan, David. "Animal Nut". Forbes. Retrieved 2018-02-16.

External links